Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1

OBJECTIVE: To investigate Tau pathology using multimodal biomarkers of neurodegeneration and neurocognition in participants with myotonic dystrophy type 1 (DM1). METHODS: We recruited twelve participants with DM1 and, for comparison, two participants with Alzheimer’s Disease (AD). Participants under...

Descripción completa

Detalles Bibliográficos
Autores principales: Laforce, Robert Jr, Dallaire-Théroux, Caroline, Racine, Annie M., Dent, Gersham, Salinas-Valenzuela, Cristian, Poulin, Elizabeth, Cayer, Anne-Marie, Bédard-Tremblay, Daphnée, Rouleau-Bonenfant, Thierry, St-Onge, Frédéric, Schraen-Maschke, Susanna, Beauregard, Jean-Mathieu, Sergeant, Nicolas, Puymirat, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217820/
https://www.ncbi.nlm.nih.gov/pubmed/35103843
http://dx.doi.org/10.1007/s00415-022-10970-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217820/
https://www.ncbi.nlm.nih.gov/pubmed/35103843
http://dx.doi.org/10.1007/s00415-022-10970-x

Ejemplares similares